comparemela.com

Latest Breaking News On - Vettafi weight loss drug - Page 1 : comparemela.com

Amplify Debuts New Weight Loss Drug ETF

Amid mounting momentum to combat global obesity, Amplify has released a new ETF that invests in the GLP-1 pharmaceutical industry.

Vettafi head of research todd rosenbluthWorld health organizationGoldman sachsAmplify weight loss drugVettafi weight loss drugTreatment indexNew index playDiet drugResearch todd rosenbluthFighting obesity usingDividend income

A New Index Play on the Diet Drug Revolution

A new poll recently published by health policy research firm KFF revealed that roughly 12% of U.S. adults have taken a diet drug.

Eli lillyUnited airlinesGoldman sachsWorld health organizationMorgan stanleyVettafi weight loss drugTreatment indexVettafis network developed world equityVettafi developed world indexNew index playDiet drug

Two US asset managers launch weight-loss ETFs

Two separate asset-management firms announced the debut of exchange-traded funds on Tuesday, both which are designed to give investors exposure to stocks like Eli Lilly & Co and Novo Nordisk.

Rhode islandUnited statesMatthew lewisSuzanne mcgeeJanus hendersonNovo nordiskEli lilly coEli lillyAmplify weight loss drugVettafi weight loss drugTreatment indexTema obesityRhode island editing

vimarsana © 2020. All Rights Reserved.